Peptides
A peptide catalog, filed and characterised.
GLP-1 and GIP agonists, GHRH analogues and research peptides — each with its classification, indication, specification and 2D structure. Click any vial to view its chemical structure.
- TirzepatideApproved
- Classification
- GLP-1 / GIP dual receptor agonist
- Indication
- Type 2 diabetes, chronic weight management
- CAS
- 2023788-19-2
- SemaglutideApproved
- Classification
- GLP-1 receptor agonist
- Indication
- Type 2 diabetes, chronic weight management
- CAS
- 910463-68-2
- RetatrutideInvestigational
- Classification
- GLP-1 / GIP / glucagon triple receptor agonist
- Indication
- Obesity, metabolic disease
- CAS
- 2381089-83-2
- SermorelinApproved
- Classification
- GHRH analogue (1-29)
- Indication
- Growth-hormone stimulation
- CAS
- 86168-78-7
- TesamorelinApproved
- Classification
- GHRH analogue (1-44)
- Indication
- HIV-associated lipodystrophy
- CAS
- 218949-48-5
- IpamorelinResearch use only
- Classification
- Ghrelin-receptor agonist (GH secretagogue)
- Indication
- Growth-hormone secretagogue (research)
- CAS
- 170851-70-4
- CJC-1295Research use only
- Classification
- GHRH analogue
- Indication
- Growth-hormone release (research)
- CAS
- 863288-34-0
- BPC-157Research use only
- Classification
- Synthetic pentadecapeptide
- Indication
- Tissue-repair research
- CAS
- 137525-51-0
- AOD-9604Research use only
- Classification
- Modified HGH fragment (176-191)
- Indication
- Fat-metabolism research
- CAS
- 221231-10-3
- MOTS-cResearch use only
- Classification
- Mitochondrial-derived peptide
- Indication
- Metabolic-regulation research
- CAS
- 1627580-64-6
- SelankResearch use only
- Classification
- Synthetic heptapeptide (tuftsin analogue)
- Indication
- Anxiolytic / nootropic research
- CAS
- 129954-34-3
- SemaxResearch use only
- Classification
- ACTH (4-10) analogue
- Indication
- Nootropic / neuroprotective research
- CAS
- 80714-61-0
- OxytocinApproved
- Classification
- Peptide hormone / neuropeptide
- Indication
- Uterotonic; obstetric use
- CAS
- 50-56-6
- NAD+Pharmaceutical grade
- Classification
- Redox coenzyme
- Indication
- Cellular energy metabolism; longevity
- CAS
- 53-84-9
Research-use peptides. Supplied strictly for laboratory research and pharmaceutical development by qualified entities. Not approved for human or veterinary use; not a medicine. Availability is subject to applicable law in the buyer's jurisdiction.